分子对接和功能分析揭示了他类药物在骨关节炎中的防护和抗炎作用
Bugrahan Regaip Kilinc1, Feyza Kostak2, Omer Faruk Yilmaz3
1Department of Biology, Institute of Natural and Applied Sciences, Namık Kemal University, Tekirdag, Turkey.
Journal of cellular and molecular medicine
|August 20, 2025
概括
皮塔瓦斯塔丁和罗斯瓦斯塔丁通过向关键分子,在骨关节炎中表现出抗炎和软骨保护作用. 然而,长期使用可能会增加细胞毒性,需要谨慎的剂量和持续时间管理.
科学领域:
- 生物化学
- 药理学
- 分子生物学
背景情况:
- 骨关节炎 (OA) 是一种由软骨破坏和炎症标志着的退行性关节疾病.
- 已知降脂的他类药物具有潜在的抗炎和冠状腺保护性.
- 皮塔瓦斯塔丁和罗斯瓦斯塔丁的治疗效果正在OA中进行研究.
研究的目的:
- 评估皮塔瓦斯塔丁和罗斯瓦斯塔丁对人体初级肌肉细胞的抗炎和肌肉保护作用.
- 使用in silico和in vitro方法阐明这些他类药物的分子机制.
- 分析包括NF-κB,IL-1β和SOX9在内的关键分子标.
主要方法:
- 在分子对接 (CB-Dock2) 和生物信息学分析 (STITCH,STRING) 中.
- 在人体初级肌肉细胞实验中评估活力和分子标.
- 西部斑点分析以量化蛋白质表达 (IL-1β,SOX9,NF-κB).
主要成果:
- 这两种他类药物对标蛋白具有强烈的结合性,而皮塔瓦斯的结合性得分更高.
- 斯塔丁抑制了IL-1β的表达,这表明它具有抗炎作用.
- 皮塔瓦斯塔丁暂时增加了SOX9,而罗斯瓦斯塔丁显示中度,持续增加;两者随着时间的推移增加了NF- kB,这表明潜在的补偿途径.
结论:
- 皮塔瓦斯塔丁和罗斯瓦斯塔丁在炎中具有双重的抗炎和冠状腺保护作用.
- 长期暴露,特别是使用罗斯瓦斯时,观察到细胞毒性作用.
- 最佳的剂量和治疗时间对于减轻副作用和最大限度地提高治疗效益至关重要.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
869
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
869
01:29Cholesterol: Significance and Regulation
678
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
678
01:20The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K